1 / 13

Meeting S-HPP Chr 16 La Cristalera , 28-29 August 2012 MRM Group Zaragoza IACS

Meeting S-HPP Chr 16 La Cristalera , 28-29 August 2012 MRM Group Zaragoza IACS Irene Orera and Sílvia Barceló-Batllori. Equipment Protein quantitation Digestion MRM Strategy: - MRM transition selection MRM transition detection in samples

iorwen
Download Presentation

Meeting S-HPP Chr 16 La Cristalera , 28-29 August 2012 MRM Group Zaragoza IACS

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Meeting S-HPP Chr 16 La Cristalera, 28-29 August 2012 MRM Group Zaragoza IACS Irene Orera and Sílvia Barceló-Batllori

  2. Equipment • Protein quantitation • Digestion • MRM Strategy: - MRM transition selection • MRM transition detection in samples • MRM evaluation, specifity and verification (MSMS) • MRM optimization (CE) • LOD, LOQ and reproducibility • Limitations

  3. Equipment: • 4000QTRAP AB Sciex • Tempo-nano MDLC • Protein quantitation: µg/µL, n=3 • Protein digestion: • In solution digestion: • -200mM DTT 30 min 37ºC • -200mM IAA 30 min ambient temperature in dark • -Trypsin gold (promega) 0.1 µg/µL in 25 mMamoniumbicarbonate: protein ratio 1:20, digestion o.n. 37ºC. • - Stop with formic acid and adjust pH<6

  4. MRM Strategy: • MRM transition selection: • - MRM pilot 2.0 : -initial peptide selection: 12 – 35 aa, no Met no Cys, 0 missed cleavage, 10 peptides per protein, +2 and +3 charge • -automatic fragment selection of 5 highest intensity of y ions (10 ideally) • - SRM Atlas • - MRM transition detection in samples: • HPLC: • TrapcolumnAcclaimPepMap 100 nano 100 um ID x 2 cm • ColumnAcclaimPepMap 100 nano 75 um x 15 cm • 3ug of protein injected • 90 min gradient (mobile phase A: 2% ACN, 0.1% Formic Acid, mobile phase B: 98% ACN, 0.1% Formic Acid

  5. MRM Strategy: • HPLC: 90 min gradient (mobile phase A: 2% ACN, 0.1% Formic Acid, mobile phase B: 98% ACN, 0.1% Formic Acid • -MS: • Ion source: nano ESI, 2800V, CUR 20psi, GS1 20psi, IHT 150ºC, DP 80V • 200 transitions/method, dwell time 50 msec • MIDAS: MRM + IDA + 2EPIs

  6. MRM evaluation, specifity and verification • a) manual revision of transitions • -coelution of different transitions corresponding to the same peptide • -good signal intensity and S/N Fructose-b aldolase GILAADESTGSIAK 666.9/907.4 +2/y9 666.9/978.5 +2/y10 666.9/1045.5 +2/y11 RT: 39,9 min

  7. Fructose-b aldolase GILAADESTGSIAK 666.9/907.4 +2/y9 666.9/978.5 +2/y10 666.9/1045.5 +2/y11 RT: 39,9 min

  8. b) proteotypic peptides: Blast http://web.expasy.org/blast/ and NCBI blast without gaps 100% identity

  9. Transitions detected in Ramosdigest

  10. In progress: • - MRM optimization (CE) • - peptide/transition verification/validation/identification (MSMS) • - LOD, LOQ and reproducibility

  11. Limitations • -Validation and specificity of MRM transitions by MSMS/MIDAS (MRM Initiated Detection and Sequencing) difficult due to sample complexity and low sensitivity of our MS equipment. • -In highly complex samples like the ones we are dealing, it is highly unlikely that the peptide corresponding to the transition will be within the most intense ones and it will be fragmented …… • Alternatives: • - validate MSMS in shot-gun high sensitive equipment (orbis or similars) • - SILAC labeling of cell culture, for transition/retention time specifity • - aqua-synthetic peptides

  12. Ebhardt, Sabidó et al, Proteomics2012 • cell culture SILAC label • peptide identification with light synthetic peptides added to heavy endogenous peptides • for transition/retention time specifity and transition order and relative intensity, allows to eliminate interfering signals • heavy synthetic peptides (aqua) for quantitation

More Related